Page 69 - CRFTApplication Compendium_090613
Basic HTML Version
Therapeutic Drug Analysis
for Clinical Research
(Click the Note number to view.)
An Improved Immunosuppressant Drug Research
Method Based on a Novel SPLC-MS/MS System
Integrated Targeted Quantitation Method for Insulin
and its Therapeutic Analogs
Development and Validation of Methods for
Chemotherapy Drugs on the New Prelude SPLC LC-MS/MS System
he Utilization of Novel Platform in a LC-MS/MS Workflow for
the Analysis of Vitamin D, Testosterone, Immunosuppressants, Chemotherapeutics
and Cortisol
herapeutic Drug Monitoring of 9 New Anticancer Agents by
High-Performance Liquid Chromatography-Tandem Mass Spectrometry
LC-MS Quantitative Screening Method for 18 Anabolic Steroids
in Oral Fluid Using MS2 Spectra Data Collected with Q Exactive Orbitrap Mass
Spectrometer
Novel On-Line Sample Cleanup and Liquid Chromatography
Platform for LC/MS Analysis in the Clinical Research Laboratory
uantitation of Immunosuppressant Drugs in Blood Utilizing Second-
Generation High-Resolution Accurate-Mass Mass Spectrometer
imultaneous Quantitative Analysis of Four Immunosuppressive Drugs
Using High Resolution Accurate Mass LC-MS
alidated LC-MS/MS Method for the Analysis of Immunosuppressant
Drugs in Whole Blood Using the RECIPE ClinMass® Complete Kit
uantitative Analysis of Mevalonate in Plasma Using LC-MS/MS
uantitative Analysis of Immunosuppressant Drugs in Whole Blood
Using High Throughput LC-MS/MS
Research Analysis of Clozapine and Norclozapine in Plasma Using
Automated Sample Preparation and LC-MS/MS
ioanalytical Assay for Neurotransmitters in Whole Blood by LC-MS/MS
etermination of Digoxin in Serum by Liquid Chromatography–Tandem
Mass Spectrometry
Improved Quantitative Selectivity of Clenbuterol in Human Urine Using
High Resolution on the TSQ Quantum Mass Spectrometer
